Anxiety and Depression in Belgium during the First 15 Months of the COVID-19 Pandemic: A Longitudinal Study [Bruggeman et al. 2022]

Bruggeman and colleagues investigated the impact of the COVID-19 crisis on the level of anxiety and depression from April 2020 to June 2021. A total of 1838 adult Belgians participated in 6 online surveys. 
Results showed that the prevalence of symptoms of anxiety and depression was higher in times of stricter policy measures. After the initial stress from the outbreak, symptoms of anxiety and depression decreased to almost the same level as in pre-COVID times. Higher levels of both anxiety and depression were generally found among women, young people, people with poor social support, extraverts, people having pre-existing psychological problems, and people who were infected/exposed to the COVID-19 virus.

The full article is available via: 





HELICON is funded by the Belgian Federal Science Policy (BELSPO) through the BRAIN-be 2.0 (2018-2023) programme.

BRAIN-be logoBELSPO logo

Information sheet for participants: EN • NL • FR

Project coordinator

Prof. dr. Brecht Devleesschauwer

Sciensano, Department of Epidemiology and Public Health, Service Health Information